HUP9900978A2 - Composition containing diosgenin - Google Patents
Composition containing diosgeninInfo
- Publication number
- HUP9900978A2 HUP9900978A2 HU9900978A HUP9900978A HUP9900978A2 HU P9900978 A2 HUP9900978 A2 HU P9900978A2 HU 9900978 A HU9900978 A HU 9900978A HU P9900978 A HUP9900978 A HU P9900978A HU P9900978 A2 HUP9900978 A2 HU P9900978A2
- Authority
- HU
- Hungary
- Prior art keywords
- vitamin
- effective amount
- therapeutically effective
- composition containing
- diosgenin
- Prior art date
Links
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 title abstract 2
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 title abstract 2
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 235000009754 Vitis X bourquina Nutrition 0.000 abstract 1
- 235000012333 Vitis X labruscana Nutrition 0.000 abstract 1
- 240000006365 Vitis vinifera Species 0.000 abstract 1
- 235000014787 Vitis vinifera Nutrition 0.000 abstract 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Abstract
A találmány tárgyát ősteőpőrősis megelőzésére és kezelésére szőlgálókészítmények képezik, amelyek terápiásan hatékőny mennyiségűdiőszgenint, terápiásan hatékőny mennyiségű K-vitamint, terápiásanhatékőny mennyiségű D-vitamint, és adőtt esetben terápiásan hatékőnymennyiségű B6-vitamint és/vagy A-vitamint tartalmaznak. Ezeket akészítményeket az azt igénylő pácienseknek őrálisan vagytranszdermálisan adják. ŕThe subject of the invention is grape preparations for the prevention and treatment of primary milk powder, which contain a therapeutically effective amount of diosgenin, a therapeutically effective amount of vitamin K, a therapeutically effective amount of vitamin D and, where appropriate, a therapeutically effective amount of vitamin B6 and/or vitamin A. These preparations are administered orally or transdermally to patients who require them. ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600604.4A GB9600604D0 (en) | 1996-01-12 | 1996-01-12 | Composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9900978A2 true HUP9900978A2 (en) | 1999-09-28 |
| HUP9900978A3 HUP9900978A3 (en) | 2001-04-28 |
Family
ID=10786934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900978A HUP9900978A3 (en) | 1996-01-12 | 1997-01-10 | Composition containing diosgenin |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5968917A (en) |
| EP (1) | EP0873125A1 (en) |
| JP (1) | JP2000503020A (en) |
| KR (1) | KR19990077143A (en) |
| CN (1) | CN1208351A (en) |
| AU (1) | AU703311B2 (en) |
| BG (1) | BG102667A (en) |
| CA (1) | CA2242589A1 (en) |
| CZ (1) | CZ219798A3 (en) |
| GB (1) | GB9600604D0 (en) |
| HU (1) | HUP9900978A3 (en) |
| IL (1) | IL125313A0 (en) |
| NO (1) | NO983184L (en) |
| NZ (1) | NZ326345A (en) |
| PL (1) | PL327833A1 (en) |
| SK (1) | SK94298A3 (en) |
| WO (1) | WO1997025049A1 (en) |
| ZA (1) | ZA97252B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713620D0 (en) * | 1997-06-28 | 1997-09-03 | Boots Co Plc | Composition |
| DK1379146T3 (en) * | 2001-03-23 | 2009-08-17 | Nutricia Nv | Preparation for the prevention and / or treatment of altered bone metabolism |
| AU2003207429A1 (en) * | 2002-02-15 | 2003-09-04 | N.V. Nutricia | Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| GB0220182D0 (en) * | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
| US20040162292A1 (en) * | 2002-12-03 | 2004-08-19 | Evenstad Kenneth L. | Multivitamin formulations for promoting healthy collagen, and methods of their use |
| US8668908B2 (en) * | 2002-12-31 | 2014-03-11 | National Yang-Ming University | Method for alleviating chemotherapy side effects using extract of Dioscorea sp |
| US20040126447A1 (en) * | 2002-12-31 | 2004-07-01 | Rong-Tsun Wu | Extract of Dioscorea sp. and the medical uses thereof |
| US20060068036A1 (en) * | 2002-12-31 | 2006-03-30 | National Yang-Ming University | Extract of Dioscorea sp. and the medical uses thereof |
| AU2004202986B2 (en) * | 2004-06-30 | 2006-09-07 | National Yang-Ming University | An extract of dioscorea sp. and the medical uses thereof |
| TWI422378B (en) * | 2010-11-18 | 2014-01-11 | Univ Chung Shan Medical | Improvement of cognitive deficit associated with menopausal syndrome with diosgenin |
| KR101480982B1 (en) * | 2013-03-20 | 2015-02-03 | (주)셀인바이오 | Osteo-induction compound and application thereof |
| CN103142640A (en) * | 2013-04-01 | 2013-06-12 | 李拖平 | Health care product containing vitamin K2 and having functions of preventing and treating brittle-bone disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05238929A (en) * | 1992-02-27 | 1993-09-17 | Sumitomo Pharmaceut Co Ltd | Long term-sustainable pharmaceutical preparation for metabolic osteopathy treatment |
-
1996
- 1996-01-12 GB GBGB9600604.4A patent/GB9600604D0/en active Pending
-
1997
- 1997-01-10 EP EP97901038A patent/EP0873125A1/en not_active Withdrawn
- 1997-01-10 CN CN97191654A patent/CN1208351A/en active Pending
- 1997-01-10 SK SK942-98A patent/SK94298A3/en unknown
- 1997-01-10 JP JP9524874A patent/JP2000503020A/en active Pending
- 1997-01-10 PL PL97327833A patent/PL327833A1/en unknown
- 1997-01-10 KR KR1019980705280A patent/KR19990077143A/en not_active Application Discontinuation
- 1997-01-10 CZ CZ982197A patent/CZ219798A3/en unknown
- 1997-01-10 US US09/101,436 patent/US5968917A/en not_active Expired - Fee Related
- 1997-01-10 HU HU9900978A patent/HUP9900978A3/en unknown
- 1997-01-10 AU AU14426/97A patent/AU703311B2/en not_active Ceased
- 1997-01-10 IL IL12531397A patent/IL125313A0/en unknown
- 1997-01-10 NZ NZ326345A patent/NZ326345A/en unknown
- 1997-01-10 CA CA002242589A patent/CA2242589A1/en not_active Abandoned
- 1997-01-10 WO PCT/EP1997/000166 patent/WO1997025049A1/en not_active Application Discontinuation
- 1997-01-13 ZA ZA9700252A patent/ZA97252B/en unknown
-
1998
- 1998-07-10 NO NO983184A patent/NO983184L/en not_active Application Discontinuation
- 1998-08-04 BG BG102667A patent/BG102667A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL327833A1 (en) | 1999-01-04 |
| SK94298A3 (en) | 1999-01-11 |
| IL125313A0 (en) | 1999-03-12 |
| NZ326345A (en) | 2000-12-22 |
| ZA97252B (en) | 1997-10-23 |
| BG102667A (en) | 1999-02-26 |
| HUP9900978A3 (en) | 2001-04-28 |
| GB9600604D0 (en) | 1996-03-13 |
| KR19990077143A (en) | 1999-10-25 |
| AU703311B2 (en) | 1999-03-25 |
| JP2000503020A (en) | 2000-03-14 |
| CN1208351A (en) | 1999-02-17 |
| CZ219798A3 (en) | 1999-02-17 |
| CA2242589A1 (en) | 1997-07-17 |
| WO1997025049A1 (en) | 1997-07-17 |
| EP0873125A1 (en) | 1998-10-28 |
| NO983184L (en) | 1998-07-10 |
| US5968917A (en) | 1999-10-19 |
| AU1442697A (en) | 1997-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053077L (en) | Therapeutic formulations for the treatment of beta-amyloid-related diseases. | |
| HUP0300426A2 (en) | Therapeutic combinations of antihypertensive and antiangiogenic agents and pharmaceutical compositions containing them | |
| HUP0105058A2 (en) | Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress | |
| HUP9901674A2 (en) | New pharmaceutical combination | |
| HUP9900978A2 (en) | Composition containing diosgenin | |
| HUP9901707A2 (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| HUP0203590A2 (en) | Remedies for diseases in association with decrease in bone mass | |
| MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
| HUP0100539A2 (en) | Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use | |
| HUP0104410A2 (en) | A composition for the prevention and/or treatment of atherosclerosis | |
| NO990934L (en) | Use of arachidonic acid and / or docosahexanoic acid in the manufacture of a medicament for the treatment of dyspraxia | |
| BR9709838A (en) | Administration regimen that provides a blood plasma profile of an h +, k + -atpase inhibitor oral pharmaceutical composition and the use of h +, k + -atpase inhibitor and processes to improve the inhibition of gastric acid secretion and the therapeutic effect on treatment of gastrointestinal disorders and to receive an extended plasma profile of an h +, k + -atpase inhibitor | |
| ITRM920270A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF SKIN AND ORAL MUCOSA INFLAMMATION. | |
| IL122196A0 (en) | Bicyclic-aromatic compounds | |
| KR970061244A (en) | Pharmaceutical composition for treating dementia | |
| PT1414473E (en) | ORAL ADMINISTRATION COMPOSITIONS FOR THE TREATMENT OF CABELUDE LEATHER DISTURBLES | |
| HUP9904073A2 (en) | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid | |
| GB9103764D0 (en) | Compositions | |
| HK1079688A1 (en) | Statin product for enhancing cognitive maintenance | |
| NO943288L (en) | Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease | |
| NO983177L (en) | Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer | |
| WO1996037183A3 (en) | Compositions capable of masking astringent taste sensations | |
| CA2385755A1 (en) | Prevention of colorectal cancer | |
| HUP9700661A2 (en) | Use of alpha-1-adrenoreceptor antagonists for the production of pharmaceuticals for profilacting and treating cancer | |
| EG17992A (en) | Preparation of a medicament for arthritis and theumatism |